Albany Medical Center
 Search
Home / Caring / Educating / Find a Doctor / News / Give Now / Careers / About / Calendar / Directions / Contact
Physician Finder Maps & Directions

INDIVIDUAL RESEARCHER

Katharine Herrick-Davis , Ph.D.
Professor
e-mail: daviskh@mail.amc.edu


Education

1988 - Ph.D. from Albany Medical College


Current Research

     5-HT receptors are members of the G-protein coupled receptor (GPCR) superfamily. GPCR are present in most if not all cells in the human body and play vital roles in cell communication and survival. They are targets for more than 50% of currently marketed pharmaceuticals. Therefore, significant emphasis has been placed on understanding molecular mechanisms governing GPCR function. GPCR are believed to form dimeric or oligomeric complexes. However, little is known about how dimer/oligomer biogenesis occurs and how it regulates GPCR function.  Currently, we are focusing on investigating receptor dimerization and how it affects receptor function using the 5-HT2C receptor as a model system. Fluorescent tags (CFP, YFP) are attached to the intracellular region of the 5-HT2C receptor and confocal microscopy is used to visualize receptor synthesis in the endoplasmic reticulum and subsequent trafficking of receptors to the plasma membrane. The effect of drug treatments on this process can be monitored. Confocal microscopy combined with fluorescence resonance energy transfer (FRET) allows us to identify potential interacting proteins, such as receptor homodimers/oliogomers or receptor interactions with other signaling proteins such as beta-arrestin.

     GFP-tagged 5-HT2C antibodies have been created and are being used to label native 5-HT2C receptors endogenously expressed in primary hippocampal neurons. State-of-the-art confocal microscopy combined with fluorescence correlation spectroscopy (FCS) and bimolecular fluorescence complementation allow direct visualization of 5-HT2C receptors and will be used to provide evidence for homodimerization of native receptors expressed in living primary cell cultures. 

 



Research Interests

5-HT pharmacology, GPCR structure and function.



Research Summary

The long-term objective of our research is to gain a better understanding of the physiological roles of serotonin (5-HT) in the central nervous system. 5-HT produces its actions by binding to specific receptors located in cell membranes. To date, 14 different 5-HT receptors have been cloned. Drugs that interact with 5-HT receptors are prescribed for anxiety, depression, schizophrenia, appetite regulation, migraine, and emesis. Drugs of abuse, such as LSD, stimulate 5-HT receptors in the brain. Molecular biology techniques are used to create genetic mutations in 5-HT receptor genes to gain a better understanding of how receptor structure is related to function. Genes for normal and mutant receptors are expressed in recombinant cell systems and evaluated for function using standard radiodligand binding and second messenger assays. Confocal microscopy is used to visualize trafficking of native and mutant receptors tagged with fluorescent proteins. Biophysical techniques (FRET, BRET) are used to explore the formation of receptor complexes (homodimers).



PubMed Publications

  1. Herrick-Davis, K., Grinde, E. and Niswender, C. (1999) 5-HT2C serotonin receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J. Neurochem. 73:1711-1717.


  2. Herrick-Davis, K., Grinde, E. and Teitler, M. (2000) Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. J. Pharmacol. Exp. Ther. 295:226-232.


  3. Niswender, C.M., Herrick-Davis, K., Dilley, G.E., Meltzer, H.Y., Overholser, J.C., Stockmeier, C.A., Emeson, R.B., and Sanders-Bush, E. (2001) RNA editing of the human serotonin 2C receptor: alterations in suicide and implications for serotonergic pharmacotherapy in psychiatric disorders. Neuropsychopharmacol. 24:478-491.


  4. Herrick-Davis, K., Grinde, E. and Mazurkiewicz, J.E. (2004) Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells. Biochemistry 43:13963-13971.


  5. Herrick-Davis, K. (2005) Constitutively active serotonin receptors. In GPCRs as drug targets. Wiley publishing, Seifert, Wieland Eds.


  6. Herrick-Davis, K., Grinde, E., Harrigan, TJ., Mazurkiewicz, JE (2005) Inhibition of serotonin 5-HT2C receptor function through heterodimerization: Receptor dimers bind two molecules of ligand and one G-protein. J. Biol. Chem. 280:40144-40151.


  7. Herrick-Davis, K., Weaver, B.A., Grinde, E., Mazurkiewicz, J.E. (2006) Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer. J. Biol. Chem. 281:27109-27116.


  8. Herrick-Davis, K., Weaver, B.A. and Grinde, E. (2007) Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment. Eur J Pharmacol. 568:45-53.